Cancer Investigation

Aims & Scope

Cancer Investigation is one of the most highly regarded and recognized journals in the field of basic and clinical oncology.

It is designed to give physicians a comprehensive resource on the current state of progress in the cancer field as well as a broad background of reliable information necessary for effective decision making.

In addition to presenting original papers of fundamental significance, it also publishes reviews, essays, specialized presentations of controversies, considerations of new technologies and their applications to specific laboratory problems, discussions of public issues, miniseries on major topics, new and experimental drugs and therapies, and an innovative letters to the editor section.

One of the unique features of the journal is its departmentalized editorial sections reporting on more than 30 subject categories covering the broad spectrum of specialized areas that together comprise the field of oncology.

Edited by leading physicians and research scientists, these sections make Cancer Investigation the prime resource for clinicians seeking to make sense of the sometimes-overwhelming amount of information available throughout the field.

In addition to its peer-reviewed clinical research, the journal also features translational studies that bridge the gap between the laboratory and the clinic.

View Aims & Scope

---

Metrics & Ranking

Impact Factor

Year	Value
2025	1.9
2024	1.80

SJR (SCImago Journal Rank)

Year	Value
2024	0.505

Quartile

Year	Value
2024	Q3

h-index

Year	Value
2024	96

Journal Rank

Year	Value
2024	11498

Journal Citation Indicator

Year	Value
2024	414

---

---

Abstracting & Indexing

Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.

• Scopus
• Google Scholar
• Web of Science
• Embase

---

Subjects & Keywords

Journal’s research areas, covering key disciplines and specialized sub-topics in Biochemistry, Genetics and Molecular Biology and Medicine, designed to support cutting-edge academic discovery.

---

Most Cited Articles

The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.

• Development of the Proteasome Inhibitor Velcadeâ„¢ (Bortezomib)

  Citation: 553

  Authors: Julian, Michael

• Pegylated Liposomal Doxorubicin: Metamorphosis of an Old Drug into a New Form of Chemotherapy

  Citation: 443

  Authors: Alberto A.

• Spontaneously Occurring Tumors of Companion Animals as Models for Human Cancer

  Citation: 393

  Authors: David M., E. Gregory

• Carcinoembryonic Antigen in the Staging and Follow-up of Patients with Colorectal Cancer

  Citation: 337

  Authors: Mitchell J., Edith Peterson

• The Etiology of Treatment-related Lymphopenia in Patients with Malignant Gliomas: Modeling Radiation Dose to Circulating Lymphocytes Explains Clinical Observations and Suggests Methods of Modifying the Impact of Radiation on Immune Cells

  Citation: 336

  Authors: Susannah, Lawrence, Stuart A., Manisha, Eric

• Soy Isoflavones and Cancer Prevention

  Citation: 314

  Authors: Fazlul H., Yiwei

• Review: Tubulin Function, Action of Antitubulin Drugs, and New Drug Development

  Citation: 268

  Authors: Federico, Daniel R

• Cell Adhesion Molecules: Role and Clinical Significance in Cancer

  Citation: 263

  Authors: Nektaria, Anastasios, Leonidas, Kostas

• Quality of Life in Cancer: Definition, Purpose, and Method of Measurement

  Citation: 234

  Authors: David F., David S.

• Upregulation of p53 Expression in Patients with Colorectal Cancer by Administration of Curcumin

  Citation: 232

  Authors: Zhen-Yu, Chuan-Bing, Hao, Fang-Long, Bao-Lin, Jie

---